Since Donald Trump’s return to power and the cuts he has made to the funding of various international bodies (and, indeed, his withdrawal of the USA from some of those bodies), the landscape of scientific research and international cooperation has changed radically in many fields that affect the common good of humanity. We have written about this repeatedly in these pages, but it is crucial to revisit the issue as time is passing and the situation is not improving. This is particularly the case where global health is concerned: the Trump 2.0 administration is currently deploying a new strategy fraught with serious consequences for world health. For insight into the nature of this new global strategy in the health field, we interviewed researcher Stéphanie Tchiombiano, a member of ‘Santé mondiale 2030’, a think-tank that published a highly instructive breakdown of the subject at the beginning of the year. She explains the new directions taken by the US administration’s health diplomacy, the economic and financial motivations behind it, its initial consequences at the international level and the risks it poses for the global health system in the medium-to-long term. An implementation of the Trumpian ‘art of the deal’ that works out more ‘lose-lose’ than ‘win-win’.
The article is downloadable only in French. It is not available in English.
